Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 17,142 shares, an increase of 1,938.3% from the September 15th total of 841 shares. Based on an average daily volume of 38,591 shares, the short-interest ratio is presently 0.4 days. Currently, 0.0% of the shares of the company are sold short.
Izotropic Price Performance
OTCMKTS:IZOZF traded down $0.00 during mid-day trading on Friday, hitting $0.12. The company’s stock had a trading volume of 126,600 shares, compared to its average volume of 22,425. The business’s fifty day moving average is $0.16 and its two-hundred day moving average is $0.18. Izotropic has a 1 year low of $0.10 and a 1 year high of $0.37.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last released its quarterly earnings data on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Research analysts expect that Izotropic will post 0.03 EPS for the current year.
Izotropic Company Profile
Izotropic Corporation is a Canadian medical technology company focused on developing advanced breast-imaging solutions. The company’s principal product is the IzoView Breast CT Imaging System, a dedicated computed tomography platform designed to produce three-dimensional images of breast tissue.
IzoView is intended to support the detection, visualization and diagnosis of breast abnormalities by providing volumetric imaging rather than conventional two-dimensional views. The system is designed to image the breast without the compression used in traditional mammography, with the goal of improving the patient experience and helping clinicians evaluate complex breast tissue.
Izotropic is focused on the continued development, validation and potential commercialization of its technology for use in breast cancer screening and diagnostic imaging.
Further Reading
- Five stocks we like better than Izotropic
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
